title: Lack of investment in regulatory science is part of "innovation gap," believes FDA commissioner.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Sukkar
mesh_terms: D035843:Biomedical Research / Q000592:standards; D017277:Drug Approval; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration / Q000191:economics*